Benzbromarone
Abdominal Obesity-Metabolic Syndrome
National Defense Medical Center, TaiwanSmall moleculePhase 4 / ApprovedDormant
B
59/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 50/ 100
- Competitive Position
- 73/ 100
Competitive context
42 Active assets in the Abdominal Obesity-Metabolic Syndrome cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Topiramate All India Institute of Medical Sciences, Bhubaneswar | Phase 4 | BBB |
Atorvastatin Seoul National University Hospital | Phase 4 | BBB |
Pioglitazone Philip Kern | Phase 4 | BBB |
Rosuvastatin Hamdard University | Phase 4 | BBB |
Simvastatin Jaime Daniel Mondragon | Phase 4 | BBB |
View all 50 →
Same molecule, other indications
Benzbromarone is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →